doi:10.3969/j.issn.1673-8640.2022.010.016

Abstract

CLC Number:

R446.7

Figures/Tables 3

References 11

[1]	SERIPA D, D'ONOFRIO G, PANZA F, et al. The genetics of the human APOE polymorphism[J]. Rejuvenation Res, 2011, 14(5):491-500. DOI PMID
[2]	HUANG W, CHEN M, ZHANG Y, et al. Frequency distribution of apolipoprotein E genotypes in elderly population and relationship with senile dementia[J]. J Neurosurg Sci, 2020, 64(1):66-70. DOI PMID
[3]	中华人民共和国国家卫生和计划生育委员会. 药物代谢酶和药物作用靶点基因检测技术指南(试行)概要[J]. 实用器官移植电子杂志, 2015, 3(5):257-267.
[4]	ZHANG L, HE S, LI Z, et al. Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia[J]. Lipids Health Dis, 2019, 18(1):129. DOI PMID
[5]	何思颖, 杜鹏辉, 张磊, 等. 血脂异常患者ApoE基因型对他汀类药物降脂疗效的影响[J]. 国际检验医学杂志, 2019, 40(11):1337-1341.
[6]	王高举, 焦红军, 周建华. ApoE基因多态性对瑞舒伐他汀治疗高脂血症疗效的影响及其机制的研究[J]. 中国医院药学杂志, 2020, 40(19):2023-2028.
[7]	张宇, 魏丹丹, 元荣荣, 等. ApoE基因多态性对阿托伐他汀治疗高脂血症疗效的影响[J]. 中华医学杂志, 2017, 97(4):291-294.
[8]	WHIRL-CARRILLO M, MCDONAGH E M, HEBERT J M, et al. Pharmacogenomics knowledge for personalized medicine[J]. Clin Pharmacol Ther, 2012, 92(4):414-417. DOI URL
[9]	中国合格评定国家认可委员会. CNAS-GL003:2018 能力验证样品均匀性和稳定性评价指南[S]. 2018.
[10]	HALLING K C, SCHRIGVER I, PERSONS D L. Test verification and validation for molecular diagnostic assays[J]. Arch Pathol Lab Med, 2012, 136(1):11-13. DOI PMID
[11]	张瑞, 李金明. 精准医学与临床实验室规范化[J]. 中华检验医学杂志, 2017, 40(4):224-226.

物品编号	rs7412		rs429358		分型结果
物品编号	预测基因型	实验室符合率/%	预测基因型	实验室符合率/%	预测基因型	实验室符合率/%
第1次
2011	CT	100.00	TT	100.00	E2/E3	100.00
2012	CC	100.00	CT	96.88	E3/E4	96.88
2013	CT	100.00	CT	96.88	E2/E4	93.75
2014	CT	100.00	TT	100.00	E2/E3	100.00
2015	CC	100.00	TT	100.00	E3/E3	96.88
第2次
2021	CT	100.00	TT	100.00	E2/E3	100.00
2022	CT	100.00	TT	100.00	E2/E3	100.00
2023	CC	100.00	CT	100.00	E3/E4	100.00
2024	CC	100.00	TT	100.00	E3/E3	100.00
2025	CT	100.00	CT	100.00	E2/E4	100.00

物品编号	rs7412		rs429358		分型结果
物品编号	预测基因型	实验室符合率/%	预测基因型	实验室符合率/%	预测基因型	实验室符合率/%
第1次
2011	CT	100.00	TT	100.00	E2/E3	100.00
2012	CC	100.00	CT	96.88	E3/E4	96.88
2013	CT	100.00	CT	96.88	E2/E4	93.75
2014	CT	100.00	TT	100.00	E2/E3	100.00
2015	CC	100.00	TT	100.00	E3/E3	96.88
第2次
2021	CT	100.00	TT	100.00	E2/E3	100.00
2022	CT	100.00	TT	100.00	E2/E3	100.00
2023	CC	100.00	CT	100.00	E3/E4	100.00
2024	CC	100.00	TT	100.00	E3/E3	100.00
2025	CT	100.00	CT	100.00	E2/E4	100.00

检测方法	回报结果实验室数		100分		80~99分		<80分
检测方法	第1次室间质评	第2次室间质评	第1次室间质评	第2次室间质评	第1次室间质评	第2次室间质评	第1次室间质评	第2次室间质评
荧光PCR法	24	21	22	21	1	0	1	0
基因杂交法	6	8	6	8	0	0	0	0
Sanger测序法	2	2	2	2	0	0	0	0
合计	32	31	30	31	1	0	1	0

检测方法	回报结果实验室数		100分		80~99分		<80分
检测方法	第1次室间质评	第2次室间质评	第1次室间质评	第2次室间质评	第1次室间质评	第2次室间质评	第1次室间质评	第2次室间质评
荧光PCR法	24	21	22	21	1	0	1	0
基因杂交法	6	8	6	8	0	0	0	0
Sanger测序法	2	2	2	2	0	0	0	0
合计	32	31	30	31	1	0	1	0

[1]	ZHOU Ying, REN Yihui, LI Guangming. Serum miR-148a expression in children with autoimmune hepatitis and its correlation with inflammatory factors [J]. Laboratory Medicine, 2023, 38(12): 1130-1134.
[2]	YAN An, GUAN Xuhuizi, YU Tian, MIAO Gang, ZHAO Yanyang. Identification of a new susceptibility gene variant EPB41L4A rs1455421289 in Chinese PTC patients by WES [J]. Laboratory Medicine, 2023, 38(11): 1009-1014.
[3]	GAO Jianchao, WANG Sisi, ZHANG Zhisheng, ZHANG Jingli, LI Xiaoxia, MA Ke, FENG Zhilin, ZHOU Haifeng, WANG Zhanhai. Efficacy and prognosis evaluation of neo-adjuvant chemotherapy for breast cancer based on miR-206，miR-125 and miR-21 [J]. Laboratory Medicine, 2023, 38(11): 1062-1068.
[4]	ZHU Qian, ZHU Lifang, MA Caiyun, YAO Jie. Relation of serum miR-140-5p and PGC-1α mRNA expression with vascular cognitive impairment in acute ischemic stroke patients [J]. Laboratory Medicine, 2023, 38(11): 1069-1074.
[5]	HUANG Zhongqiang, DAI Di, HOU Tieying, LIN Faquan, LU Zhiming, LIU Xiaoqi, SHEN Minna, WU Jie, ZHANG Pingan, ZHOU Jun, XIAO Yanqun, WANG Hualiang. Multicenter performance evaluation of a 7-microRNA test kit [J]. Laboratory Medicine, 2023, 38(11): 1075-1081.
[6]	XUE Yaze, HE Jin, TANG Shaojun. Roles of serum miR-150-5p and LTBP-2 determinations in evaluating the condition of acute cerebral infarction patients [J]. Laboratory Medicine, 2023, 38(11): 1082-1086.
[7]	. [J]. Laboratory Medicine, 2023, 38(11): 1106-1108.
[8]	GUO Mingri, LI Yuming, LI Yan, SUN Haibai. Difference in identification of non-tuberculous Mycobacterium between microarray chip and multiple homologous sequence [J]. Laboratory Medicine, 2023, 38(10): 909-914.
[9]	ZHOU Jun, LI Liheng, ZHANG Min. Expressions of serum miR-24 and XIAP mRNA in serum of oral adenoid cystic carcinoma patients and relationship with prognosis [J]. Laboratory Medicine, 2023, 38(10): 930-935.
[10]	LI Liangshan, ZHAO Hu, WANG Shiwen. Screening potential prognostic biomarkers of colorectal cancer based on weighted gene co-expression network analysis [J]. Laboratory Medicine, 2023, 38(9): 825-832.
[11]	WANG Wei, ZHANG Zhixin, ZHANG Chuanbao, ZHOU Weiyan, WANG Zhiguo. Establishment of allowable total error，allowable imprecision and allowable bias for 22 endocrine analytes [J]. Laboratory Medicine, 2023, 38(8): 707-712.
[12]	Clinical Laboratory Society of Chinese Association for Rehabilitation Medicine , Molecular Diagnostics Society of Shanghai Medical Association , Tumor Immunology Branch of Shanghai Society for Immunology , Yueyang Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai University of Traditional Chinese Medicine , Shanghai Center for Clinical Laboratory, Clinical Laboratory Society of Chinese Association of Integrative Medicine , Clinical Laboratory Society of Shanghai Anticancer Association , Tumor Markers Society of Shanghai Anticancer Association . Expert consensus on the clinical application of AFP，AFP-L3% and DCP using GALAD and GALAD-like models in hepatocellular carcinoma [J]. Laboratory Medicine, 2023, 38(7): 607-623.
[13]	ZHANG Xin, MA Lijuan. Role of cardiac markers in children [J]. Laboratory Medicine, 2023, 38(6): 505-509.
[14]	LIU Ruili, LI Lanjun, JIA Minlei, WANG Yihui, HAO Weina. Correlation between tumor miR-7-5p and NOVA2 levels and clinical prognosis in cancer tissues of patients with gastric cancer [J]. Laboratory Medicine, 2023, 38(4): 325-329.
[15]	WANG Xin, DENG Qian, WANG Juanjuan, CAI Wenjuan, GAO Jian, HAN Yanping, HU Kefei, CHEN Yuqing. Clinical characteristics and genetic analysis of Desbuquois dysplasia Kim type caused by CANT1 mutation [J]. Laboratory Medicine, 2023, 38(2): 130-136.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 11

Related Articles 15

Recommended Articles

Metrics